International Journal of Biological Macromolecules,
Journal Year:
2021,
Volume and Issue:
181, P. 582 - 604
Published: March 23, 2021
Many
neurodegenerative
diseases
are
rooted
in
the
activities
of
amyloid-like
proteins
which
possess
conformations
that
spread
to
healthy
proteins.
These
include
Alzheimer's
disease
(AD),
Parkinson's
(PD),
Huntington's
(HD)
and
amyotrophic
lateral
sclerosis
(ALS).
While
their
clinical
manifestations
vary,
protein-level
mechanisms
remarkably
similar.
Aberrant
monomeric
undergo
conformational
shifts,
facilitating
aggregation
formation
solid
fibrils.
However,
there
is
growing
evidence
intermediate
oligomeric
stages
key
drivers
neuronal
toxicity.
Analysis
protein
dynamics
complicated
by
fact
nucleation
growth
not
a
linear
pathway.
Feedback
within
this
pathway
results
exponential
acceleration
aggregation,
but
exerted
oligomers
fibrils
can
alter
cellular
interactions
environment
as
whole.
The
resulting
cascade
effects
likely
contributes
late
onset
accelerating
progression
disorders
widespread
they
have
on
body.
In
review
we
explore
associated
with
AD,
PD,
HD
ALS,
well
common
aggregation.
From
this,
identify
core
elements
pathological
been
targeted
for
therapies,
may
become
future
therapeutic
targets.
International Journal of Molecular Sciences,
Journal Year:
2020,
Volume and Issue:
21(12), P. 4477 - 4477
Published: June 24, 2020
It
is
widely
accepted
that
β-amyloid
oligomers
(Aβos)
play
a
key
role
in
the
progression
of
Alzheimer's
disease
(AD)
by
inducing
neuron
damage
and
cognitive
impairment,
but
Aβos
are
highly
heterogeneous
their
size,
structure
cytotoxicity,
making
corresponding
studies
tough
to
carry
out.
Nevertheless,
number
have
recently
made
remarkable
progress
describing
characteristics
pathogenicity
Aβos.
We
here
review
mechanisms
which
exert
neuropathogenesis
for
AD
progression,
including
receptor
binding,
cell
membrane
destruction,
mitochondrial
damage,
Ca2+
homeostasis
dysregulation
tau
pathological
induction.
also
summarize
such
as
morphology
cytotoxicity
dimers,
trimers,
Aβ*56
spherical
oligomers,
suggest
may
different
at
phases
pathogenesis,
resulting
differential
consequences
on
neuronal
synaptotoxicity
survival.
warranted
investigate
temporal
sequence
human
brain
examine
relationship
between
impairment.
The
formation
of
misfolded
protein
aggregates
is
a
hallmark
neurodegenerative
diseases.
aggregate
process
exhibits
an
initial
lag
phase
when
precursor
clusters
spontaneously
assemble.
However,
most
experimental
assays
are
blind
to
this
phase.
We
develop
quantitative
assay
based
on
super-resolution
imaging
in
fixed
cells
and
light
sheet
living
study
the
early
steps
aggregation
mammalian
cells.
find
that
even
under
normal
growth
conditions
have
clusters.
cluster
size
distribution
precisely
expected
for
so-called
super-saturated
system
first
order
transition.
This
means
there
exists
nucleation
barrier,
critical
above
which
grow
mature.
Homeostasis
maintained
through
Szilard
model
entailing
preferential
clearance
super-critical
uncover
role
putative
chaperone
(RuvBL)
disassembly
large
results
indicate
behave
like
condensates.
Editorial
note:
article
has
been
editorial
authors
decide
how
respond
issues
raised
during
peer
review.
Reviewing
Editor's
assessment
all
addressed
(<xref
ref-type="decision-letter"
rid="SA1">see
decision
letter</xref>).
Molecules,
Journal Year:
2020,
Volume and Issue:
25(7), P. 1659 - 1659
Published: April 3, 2020
The
structural
polymorphism
and
the
physiological
pathophysiological
roles
of
two
important
proteins,
β-amyloid
(Aβ)
tau,
that
play
a
key
role
in
Alzheimer’s
disease
(AD)
are
reviewed.
Recent
results
demonstrate
monomeric
Aβ
has
functions.
Toxic
oligomeric
assemblies
(AβOs)
may
decisive
AD
pathogenesis.
polymorph
fibrillar
(fAβ)
form
very
ordered
cross-β
structure
is
assumed
to
be
non-toxic.
Tau
monomers
also
have
several
actions;
however,
their
oligomerization
leads
toxic
oligomers
(TauOs).
Further
polymerization
probably
non-toxic
structures,
among
others
neurofibrillary
tangles
(NFTs).
Their
was
determined
by
cryo-electron
microscopy
at
atomic
level.
Both
AβOs
TauOs
initiate
neurodegenerative
processes,
interactions
crosstalk
determine
changes
AD.
(perhaps
AβO)
prionoid
character,
they
responsible
for
cell-to-cell
spreading
disease.
extra-
intracellular
(and
not
previously
hypothesized
amyloid
plaques
NFTs)
represent
novel
targets
drug
research.
Pure and Applied Chemistry,
Journal Year:
2019,
Volume and Issue:
91(2), P. 211 - 229
Published: Feb. 1, 2019
Abstract
Inhibition
of
amyloid
β
peptide
(Aβ)
aggregation
is
an
important
goal
due
to
the
connection
this
process
with
Alzheimer’s
disease.
Traditionally,
inhibitors
were
developed
aim
retard
overall
macroscopic
aggregation.
However,
recent
advances
imply
that
approaches
based
on
mechanistic
insights
may
be
more
powerful.
In
such
approaches,
microscopic
steps
underlying
are
identified,
and
it
established
which
these
step(s)
lead
neurotoxicity.
Inhibitors
then
derived
specifically
target
involved
in
toxicity.
The
Aβ
composed
at
minimum
three
steps:
primary
nucleation
monomers
only,
secondary
fibril
surface,
elongation
fibrils
by
monomer
addition.
vast
majority
toxic
species
generated
from
process:
a
key
inhibit
order
limit
nucleation,
delays
emergence
without
affecting
their
total
concentration,
also
effective.
instead
increase
toxicity
over
time.
Here
we
briefly
review
findings
regarding
Aβ,
its
dominance
attempts
derive
International Journal of Biological Macromolecules,
Journal Year:
2021,
Volume and Issue:
181, P. 582 - 604
Published: March 23, 2021
Many
neurodegenerative
diseases
are
rooted
in
the
activities
of
amyloid-like
proteins
which
possess
conformations
that
spread
to
healthy
proteins.
These
include
Alzheimer's
disease
(AD),
Parkinson's
(PD),
Huntington's
(HD)
and
amyotrophic
lateral
sclerosis
(ALS).
While
their
clinical
manifestations
vary,
protein-level
mechanisms
remarkably
similar.
Aberrant
monomeric
undergo
conformational
shifts,
facilitating
aggregation
formation
solid
fibrils.
However,
there
is
growing
evidence
intermediate
oligomeric
stages
key
drivers
neuronal
toxicity.
Analysis
protein
dynamics
complicated
by
fact
nucleation
growth
not
a
linear
pathway.
Feedback
within
this
pathway
results
exponential
acceleration
aggregation,
but
exerted
oligomers
fibrils
can
alter
cellular
interactions
environment
as
whole.
The
resulting
cascade
effects
likely
contributes
late
onset
accelerating
progression
disorders
widespread
they
have
on
body.
In
review
we
explore
associated
with
AD,
PD,
HD
ALS,
well
common
aggregation.
From
this,
identify
core
elements
pathological
been
targeted
for
therapies,
may
become
future
therapeutic
targets.